Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bristol Randomised Controlled Trial of Zoledronic Acid in Malignant Pleural Disease (Pilot Study)
2009-009134-32Phase 4Completed
- Sponsor
- North Bristol NHS Trust
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of zoledronic acid in Pleural carcinoma (2 arms), sponsored by North Bristol NHS Trust. Primary endpoint: Change in gadolinium uptake and washout rate on DCE-MRI. Started Apr 2009; status: completed.
02
Drugs
zoledronic acid
03
Conditions
Pleural carcinoma
Beyond the preview
Go deeper on 2009-009134-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009134-32.